Fund moves

Minimed Group (MMED)Longaeva Partners L.P. opened a new position $47.4M

Longaeva Partners L.P. opened a new position in Minimed Group, per its Q1 2026 13F.

3.18M
Shares reported
1.8%
Disclosed portfolio weight
$47.4M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 23, 2026, the Compensation and Talent Committee (the “ Committee ”) of the Board of Directors of MiniMed Group, Inc. (the “ Company ”) approved the MiniMed Severance Pay Plan for Executives (the “ Severance Plan ”) and applicable severance benefit practices and levels that would be applicable to the Company’s named executive officers and the MiniMed Group, Inc. Change of Control Severance Plan (the “ COC…”

What came next

  1. May 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 17, 2026, Brett Wall, a class II director of the Board of Directors (the “Board”) of MiniMed Group, Inc. (“MiniMed”) and member of the Board’s Nominating and Corporate Governance Committee, notified the Board that he will resign from the Board effective July 3, 2026.”
  2. Jun 3, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. Jun 25, 2026Company filing · Form 8-K · Executive change, Shareholder Director NominationsChanged a top executive or board member, and set the date for shareholder nominations (and 1 more item)“On June 25, 2026, the Board of Directors (the “Board”) of MiniMed Group, Inc. (“MiniMed”) increased the size of the Board from nine to 11 and appointed David Endicott and Linnea Burman to serve as a directors of the Board to fill the resulting vacancies, effective June 29, 2026.”
  4. Jul 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 30, 2026, Courtney Nelson Wills, Senior Vice President, General Counsel and Corporate Secretary, notified MiniMed Group, Inc. (“MiniMed”) of her decision to resign from her position, effective September 25, 2026, following an 8-week transition period.”
  5. Sep 1, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Minimed Group

For Minimed Group, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MMED page.

How this filing works

Other disclosures at Minimed Group

Everything OQRO holds on this company is on its MMED page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data